These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10686467)

  • 21. Predicting Long-Term Outcome of Patients of Early Parkinsonism with Acute Levodopa Challenge Test.
    Acharya M; Banerjee S; Chatterjee A; Mukherjee A; Biswas S; Gangopadhyay G; Biswas A
    Neurol India; 2021; 69(2):430-434. PubMed ID: 33904468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.
    Nyholm D; Constantinescu R; Holmberg B; Dizdar N; Askmark H
    Acta Neurol Scand; 2009 May; 119(5):345-8. PubMed ID: 18822087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenge tests to predict the dopaminergic response in untreated Parkinson's disease.
    Hughes AJ; Lees AJ; Stern GM
    Neurology; 1991 Nov; 41(11):1723-5. PubMed ID: 1944899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apomorphine test for dopaminergic responsiveness: a dose assessment study.
    Bonuccelli U; Piccini P; Del Dotto P; Rossi G; Corsini GU; Muratorio A
    Mov Disord; 1993 Apr; 8(2):158-64. PubMed ID: 8474482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson's disease.
    Calandra-Buonaura G; Doria A; Lopane G; Guaraldi P; Capellari S; Martinelli P; Cortelli P; Contin M
    J Neurol; 2016 Feb; 263(2):250-256. PubMed ID: 26566913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease.
    Gasser T; Schwarz J; Arnold G; Trenkwalder C; Oertel WH
    Arch Neurol; 1992 Nov; 49(11):1131-4. PubMed ID: 1444878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which Scale Best Detects Treatment Response of Tremor in Parkinsonism?
    Pintér D; Forjaz MJ; Martinez-Martin P; Rodriguez-Blazquez C; Ayala A; Juhász A; Harmat M; Janszky J; Kovács N
    J Parkinsons Dis; 2020; 10(1):275-282. PubMed ID: 31868685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease.
    Hauser RA; Olanow CW; Dzyngel B; Bilbault T; Shill H; Isaacson S; Dubow J; Agro A
    Mov Disord; 2016 Sep; 31(9):1366-72. PubMed ID: 27430123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report.
    Defazio G; De Mari M; De Salvia R; Lamberti P; Giorelli M; Livrea P
    Clin Neuropharmacol; 1999; 22(5):292-4. PubMed ID: 10516881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute dopaminergic responsiveness test in diagnosis of Parkinson's disease and Parkinsonian disorders].
    Li W; Feng T; Wang YJ; Lin JX; Xu XT
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2347-9. PubMed ID: 19087697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levodopa responsiveness in disorders with parkinsonism: a review of the literature.
    Constantinescu R; Richard I; Kurlan R
    Mov Disord; 2007 Nov; 22(15):2141-8; quiz 2295. PubMed ID: 17534959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism.
    Krismer F; Pinter B; Mueller C; Mahlknecht P; Nocker M; Reiter E; Djamshidian-Tehrani A; Boesch SM; Wenning GK; Scherfler C; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2017 Feb; 35():36-41. PubMed ID: 27890451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apomorphine test in de novo Parkinson's disease.
    Bonuccelli U; Piccini P; Del Dotto P; Pavese N; D'Antonio P; Muratorio A
    Funct Neurol; 1992; 7(4):295-8. PubMed ID: 1427361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CART modulates the effects of levodopa in rat model of Parkinson's disease.
    Upadhya MA; Shelkar GP; Subhedar NK; Kokare DM
    Behav Brain Res; 2016 Mar; 301():262-72. PubMed ID: 26771081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.
    Martinez-Martin P; Reddy P; Katzenschlager R; Antonini A; Todorova A; Odin P; Henriksen T; Martin A; Calandrella D; Rizos A; Bryndum N; Glad A; Dafsari HS; Timmermann L; Ebersbach G; Kramberger MG; Samuel M; Wenzel K; Tomantschger V; Storch A; Reichmann H; Pirtosek Z; Trost M; Svenningsson P; Palhagen S; Volkmann J; Chaudhuri KR
    Mov Disord; 2015 Apr; 30(4):510-6. PubMed ID: 25382161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical usefulness of apomorphine in movement disorders.
    Colosimo C; Merello M; Albanese A
    Clin Neuropharmacol; 1994 Jun; 17(3):243-59. PubMed ID: 9316670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease.
    Priano L; Albani G; Calderoni S; Baudo S; Lopiano L; Rizzone M; Astolfi V; Cavalli R; Gasco MR; Fraschini F; Bergamasco B; Mauro A
    Neurol Sci; 2002 Sep; 23 Suppl 2():S99-100. PubMed ID: 12548362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apomorphine and levodopa challenge in patients with a focal midbrain lesion.
    Moro E; Albanese A
    Mov Disord; 1999 Mar; 14(2):269-75. PubMed ID: 10091621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does clinical intolerance to a diagnostic acute levodopa challenge differentiate multiple system atrophy from PD?
    Estévez S; Perez-Lloret S; Merello M
    Int J Neurosci; 2009; 119(12):2257-61. PubMed ID: 19916854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders.
    Lamberti P; De Mari M; Zenzola A; Aniello MS; Defazio G
    Neurol Sci; 2002 Sep; 23 Suppl 2():S81-2. PubMed ID: 12548354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.